V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280004170 | 280002980 | 1.72 | 79 | Palliative (P) | 2015-09-14 | 2015-09-14 | Cisplatin + Gemcitabine (D 1 & 8) | 01 | N | 280026847 | CISPLATIN + GEMCITABINE |
| 280004171 | 280002981 | 1.72 | 83.5 | Palliative (P) | 2016-01-21 | 2016-02-02 | Cisplatin + Gemcitabine (D 1 & 8) | 99 | N | 280026862 | CISPLATIN + GEMCITABINE |
| 280004172 | 280002981 | 1.57 | 69.6 | null | 2016-08-13 | 2016-08-13 | CARBOPLATIN + PACLITAXEL | 2 | N | 280026862 | CARBOPLATIN + PACLITAXEL |
| 280004173 | 280002981 | 1.65 | 98 | null | 2015-02-19 | 2015-02-25 | Carboplatin AUC 6 - 10 | N | N | 280026862 | CARBOPLATIN |
| 280004174 | 280002982 | 1.75 | 66.3 | Palliative (P) | 2015-10-26 | 2015-11-17 | Cetuximab 7 day (Cycle 1) | 02 | N | 280026865 | CETUXIMAB |
| 280004175 | 280002983 | 1.61 | 72.5 | Palliative (P) | 2016-11-01 | 2016-11-15 | Carboplatin AUC 2 - 5 | Y | N | 280026866 | CARBOPLATIN |
| 280004176 | 280007485 | 1.66 | null | Palliative (P) | 2016-01-31 | 2016-02-02 | Trial Unspecified | 02 | N | 280026869 | TRIAL |
| 280004177 | 280002984 | 1.85 | 25 | Neo-adjuvant (N) | 2017-05-31 | 2017-06-07 | Trial Unspecified | null | null | 280026871 | TRIAL |
| 280004178 | 280002985 | 1.78 | 45 | Not known (9) | 2013-08-14 | 2013-08-19 | Carboplatin AUC 2 - 5 | N | N | 280026874 | CARBOPLATIN |
| 280004179 | 280007486 | 1.85 | 87.8 | Palliative (P) | 2014-05-07 | 2014-05-07 | CETUXIMAB | 02 | null | 280026875 | CETUXIMAB |
| 280004180 | 280002986 | 1.73 | 74 | Palliative (P) | 2017-08-04 | 2017-08-22 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280026884 | CISPLATIN + GEMCITABINE |
| 280004181 | 280002986 | 1.9 | 88 | Palliative (P) | 2017-06-28 | 2017-06-28 | EOX | N | N | 280026884 | EOX |
| 280004182 | 280002987 | 1.74 | 82.7 | Palliative (P) | 2017-02-14 | 2017-03-07 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 280026889 | CARBOPLATIN + PACLITAXEL |
| 280004183 | 280002987 | null | 78.7 | Not known (9) | 2017-03-25 | 2017-04-02 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | 280026889 | NOT MATCHED |
| 280004184 | 280002987 | 1.6 | 58 | Neo-adjuvant (N) | 2014-03-13 | 2014-03-20 | Cetuximab 7 day (Cycle 1) | N | null | 280026889 | CETUXIMAB |
| 280004185 | 280002988 | 1.65 | 88.4 | null | 2015-06-06 | 2015-06-15 | Cetuximab 7 day (Cycle 1) | 02 | N | 280026892 | CETUXIMAB |
| 280004186 | 280007489 | 1.46 | 53.35 | Palliative (P) | 2014-08-17 | 2014-08-20 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | 280026893 | NOT MATCHED |
| 280004187 | 280007489 | 1.79 | 72.25 | Palliative (P) | 2017-03-26 | 2017-04-24 | CARBOPLATIN + RT | N | N | 280026893 | CARBOPLATIN + RT |
| 280004188 | 280007489 | null | 78.9 | Palliative (P) | 2013-09-11 | 2013-09-11 | Carboplatin AUC 2 - 5 | null | null | 280026893 | CARBOPLATIN |
| 280004189 | 280007489 | 1.81 | 4.3 | Palliative (P) | 2014-10-16 | 2014-10-23 | STS Non-Rhabdo EpSSG 2005 VBL/MTX | 2 | N | 280026893 | NOT MATCHED |
| 280004190 | 280002989 | null | 68.5 | Palliative (P) | null | 2016-10-20 | Carboplatin AUC 2 - 5 | N | N | 280026901 | CARBOPLATIN |
| 280004191 | 280002989 | 0 | 72.1 | Palliative (P) | 2014-02-16 | 2014-02-19 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | N | N | 280026901 | NOT MATCHED |
| 280004192 | 280002989 | 1.52 | null | null | 2017-03-12 | 2017-03-24 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | 280026901 | NOT MATCHED |
| 280004193 | 280010964 | 1.7 | null | Palliative (P) | null | 2017-02-12 | Carboplatin AUC 6 - 10 | N | N | 280026905 | CARBOPLATIN |
| 280004194 | 280002990 | 1.51 | 88.4 | Palliative (P) | 2017-12-19 | 2018-01-04 | Cetuximab 7 day (Cycle 1) | 02 | N | 280026908 | CETUXIMAB |
| 280004195 | 280002990 | 1.8 | 91 | Palliative (P) | null | 2016-06-08 | Carboplatin AUC 2 - 5 | 2 | N | 280026908 | CARBOPLATIN |
| 280004196 | 280002990 | 1.8 | 132 | Adjuvant (A) | 2017-12-12 | 2017-12-17 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 280026908 | CARBOPLATIN + PACLITAXEL |
| 280004197 | 280002990 | 1.56 | null | Palliative (P) | 2018-02-03 | 2018-02-07 | Carboplatin AUC 2 - 5 | N | null | 280026908 | CARBOPLATIN |
| 280004198 | 280002991 | 1.73 | 64.3 | Adjuvant (A) | null | 2016-11-23 | Trial Unspecified | Y | null | 280026918 | TRIAL |
| 280004199 | 280007492 | 1.76 | null | Palliative (P) | 2016-02-21 | 2016-02-28 | CETUXIMAB | null | null | 280026919 | CETUXIMAB |
| 280004200 | 280002992 | 1.6 | null | Palliative (P) | 2017-05-15 | 2017-06-05 | CISPLATIN + GEMCITABINE | Y | N | 280026920 | CISPLATIN + GEMCITABINE |
| 280004201 | 280002993 | 1.67 | 66.5 | Not known (9) | 2015-11-12 | 2015-12-14 | Trial Unspecified | 2 | N | 280026921 | TRIAL |
| 280004202 | 280002993 | 1.68 | 76.5 | Palliative (P) | 2013-09-04 | 2013-09-15 | Cetuximab 7 day (Cycle 1) | Y | N | 280026921 | CETUXIMAB |
| 280004203 | 280002994 | 1.68 | 63 | null | 2016-02-14 | 2016-02-14 | Carboplatin AUC 2 - 5 | N | N | 280026924 | CARBOPLATIN |
| 280004204 | 280002994 | null | 45.9 | Palliative (P) | 2014-02-01 | 2014-02-04 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 280026924 | CISPLATIN + GEMCITABINE |
| 280004205 | 280002995 | 1.7 | 17.5 | Palliative (P) | 2013-12-31 | 2014-01-01 | Trial Unspecified | 02 | N | 280026927 | TRIAL |
| 280004206 | 280002995 | 1.63 | 67.4 | Palliative (P) | 2016-01-25 | 2016-02-07 | Cetuximab 7 day (Cycle 1) | N | N | 280026927 | CETUXIMAB |
| 280004207 | 280002995 | 1.62 | null | null | 2015-03-11 | 2015-03-11 | CARBOPLATIN + ETOPOSIDE | null | null | 280026927 | CARBOPLATIN + ETOPOSIDE |
| 280004208 | 280002995 | 1.72 | 69.2 | Palliative (P) | 2014-03-30 | 2014-04-18 | CARBOPLATIN | 2 | N | 280026927 | CARBOPLATIN |
| 280004209 | 280002995 | 1.6 | 55 | null | 2017-01-06 | 2017-01-23 | Carboplatin AUC 2 - 5 | N | N | 280026927 | CARBOPLATIN |
| 280004210 | 280002996 | 1.88 | 76 | Palliative (P) | 2013-02-20 | 2013-03-21 | Cetuximab 7 day (Cycle 1) | N | N | 280026935 | CETUXIMAB |
| 280004211 | 280002997 | 1.8 | 76.1 | Palliative (P) | 2015-01-16 | 2015-01-17 | EOX | N | null | 280026939 | EOX |
| 280004212 | 280002997 | 1.68 | 14.7 | Palliative (P) | 2014-01-05 | 2014-01-05 | CARBOPLATIN | N | N | 280026939 | CARBOPLATIN |
| 280004213 | 280002998 | null | 116 | Palliative (P) | 2013-02-07 | 2013-02-11 | Carboplatin + Etoposide iv&po | 02 | null | 280026947 | CARBOPLATIN + ETOPOSIDE |
| 280004214 | 280002998 | 1.73 | null | Palliative (P) | 2016-03-30 | 2016-03-31 | Trial Unspecified | Y | null | 280026947 | TRIAL |
| 280004215 | 280002999 | 0 | 15.9 | Palliative (P) | 2015-03-09 | 2015-03-25 | Cetuximab 7 day (Cycle 1) | N | N | 280026950 | CETUXIMAB |
| 280004216 | 280002999 | 1.63 | 92.1 | null | 2016-08-29 | 2016-08-31 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 280026950 | CISPLATIN + GEMCITABINE |
| 280004217 | 280003000 | 1.65 | 79 | Palliative (P) | 2017-01-20 | 2017-01-26 | CISPLATIN + GEMCITABINE | 02 | 2 | 280026953 | CISPLATIN + GEMCITABINE |
| 280004218 | 280003000 | 1.61 | null | Palliative (P) | null | 2016-12-12 | CARBOPLATIN + RT | null | null | 280026953 | CARBOPLATIN + RT |
| 280004219 | 280003001 | 1.71 | 67 | null | 2014-01-18 | 2014-01-19 | Cetuximab 7 day (Cycle 1) | N | N | 280026958 | CETUXIMAB |